Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 9 ... include novel combination of well-know agents such as rituximab and chlorambucil, fludarabine, cyclophosphamide and alemtuzumab, FCR with mitoxantrone amongst many. Consolidation ...
2009 NOV 16 ... stem cell transplantation from an unrelated donor after being conditioned with fludarabine, melphalan, and total body irradiation." "Tacrolimus and methotrexate ...
2009 NOV 2 ... from Leukine® (sargramostim), Campath® (alemtuzumab) and Fludara® (fludarabine phosphate), following the closing of the transaction with Bayer at the end of May. ...
2009 OCT 12 ... trial investigating Campath® (alemtuzumab) in combination with Fludara® (fludarabine phosphate) in relapsed or refractory chronic lymphocytic leukemia (CLL) patients met its ...
2009 NOV 16 ... of HPS to engraftment failure after CBT, following preparative regimens containing fludarabine phosphate, in 119 patients (median age, 55 years; range; 17-69 years) with ...
2009 NOV 2 ... clinical outcome predictors in CLL patients in remission following treatment with oral fludarabine plus cyclophosphamide,' are detailed in a study published in Annals of Hematology. ...
2009 NOV 9 ... after a conditioning regimen consisting of low-dose total body irradiation and fludarabine. The prophylaxis for graft-versus-host disease consisted of mycophenolate mofetil and ...
2009 NOV 16 ... a median of two cycles of MGCD0103 (range, 0-12). All patients had previously received fludarabine, 33% were fludarabine refractory, and 71% had ...
2009 NOV 2 ... 'Thalidomide exerts distinct molecular antileukemic effects and combined thalidomide/fludarabine therapy is clinically effective in high-risk chronic lymphocytic leukemia,' is newly ...
2009 OCT 12 ... CBT at our institute, in which preparative regimens mainly consisted of fludarabine, melphalan, and total body irradiation with graft-versus-host (GVH) disease prophylaxis ...
2009 NOV 1 ... (HSCT) as first-line therapy for severe acquired idiopathic aplastic anemia (SAA). Fludarabine (Flu)-based conditioning might improve outcome in older patients," researchers in ...
2009 NOV 2 ... in first (n=30) or second (n=7) complete remission (CR). All patients were treated with fludarabine (150 mg/m2) and melphalan (140 mg/m2) followed by transplantation from matched sibling ...
2009 OCT 26 ... researchers concluded: "This provides a rationale for combinations of lenalidomide with fludarabine or alemtuzumab." Aue and colleagues published their study in Haematologica ...
2009 NOV 23 ... (HCT) recipients receiving alemtuzumab-based conditioning. Fifty-two received fludarabine/melphalan, 44 received fludarabine/busulfan, and 24 ...
2009 OCT 19 ... antibodies YTH24.5 and YTH 54.12 for myelosuppression, and alemtuzumab (anti-CD52) and fludarabine, and low dose cyclophosphamide for immunosuppression. Donors were matched siblings ...
2009 NOV 9 ... in the United States report. "Conditioning for salvage HCT consisted of fludarabine (Flu) and either 3 or 4 Gy total body irradiation (TBI). Sustained engraftment was ...
2009 NOV 9 ... options and decreased overall survival. Dysfunction of p53 leads to resistance to fludarabine-based therapies." "Cyclin-dependent kinase inhibitors (CDKi) are a novel ...
2009 NOV 2 ... tolerated and had promising activity when used in combination to treat patients with fludarabine-refractory chronic lymphocytic leukemia (CLL). This prompted us to evaluate the use of ...
